PatentsGlobal
Decoy Therapeutics Broadens Patent Portfolio for Designable Multi-Antivirals and IMP³ACT™ Platform
Decoy Therapeutics Inc. has expanded its intellectual property holdings to encompass seven patent families and 19 pending applications worldwide. The portfolio safeguards antiviral peptide conjugates, manufacturing methods, formulations, and the IMP³ACT™ design platform that underpins its Designable Multi-Antivirals (…
Monday, August 3, 2026